DE10085183T1 - Preparation of an HMG-COA reductase inhibitor with prolonged release - Google Patents

Preparation of an HMG-COA reductase inhibitor with prolonged release

Info

Publication number
DE10085183T1
DE10085183T1 DE10085183T DE10085183T DE10085183T1 DE 10085183 T1 DE10085183 T1 DE 10085183T1 DE 10085183 T DE10085183 T DE 10085183T DE 10085183 T DE10085183 T DE 10085183T DE 10085183 T1 DE10085183 T1 DE 10085183T1
Authority
DE
Germany
Prior art keywords
hmg
preparation
coa reductase
reductase inhibitor
prolonged release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE10085183T
Other languages
German (de)
Inventor
Chih-Ming Chen
Joseph Chou
David Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Andrx Laboratories LLC
Original Assignee
Andrx Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andrx Corp filed Critical Andrx Corp
Publication of DE10085183T1 publication Critical patent/DE10085183T1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE10085183T 1999-11-08 2000-11-03 Preparation of an HMG-COA reductase inhibitor with prolonged release Ceased DE10085183T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43557699A 1999-11-08 1999-11-08
PCT/US2000/030415 WO2001034123A1 (en) 1999-11-08 2000-11-03 Hmg-coa reductase inhibitor extended release formulation

Publications (1)

Publication Number Publication Date
DE10085183T1 true DE10085183T1 (en) 2002-10-24

Family

ID=23728948

Family Applications (1)

Application Number Title Priority Date Filing Date
DE10085183T Ceased DE10085183T1 (en) 1999-11-08 2000-11-03 Preparation of an HMG-COA reductase inhibitor with prolonged release

Country Status (8)

Country Link
AU (1) AU768950B2 (en)
CA (1) CA2390301A1 (en)
DE (1) DE10085183T1 (en)
GB (1) GB2371748B (en)
HK (1) HK1050134A1 (en)
IL (1) IL149524A0 (en)
NZ (1) NZ518770A (en)
WO (1) WO2001034123A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050089572A1 (en) * 2002-03-22 2005-04-28 Manoj Kumar Controlled release drug delivery system of pravastatin
PL375411A1 (en) * 2002-09-03 2005-11-28 Biovail Laboratories, Inc. Pharmaceuticals formulations and methods for modified release of statin drugs
US20090196889A1 (en) * 2004-11-22 2009-08-06 Dexcel Pharma Technologies Ltd. Controlled absorption of statins in the intestine
WO2008044236A2 (en) * 2006-10-10 2008-04-17 Dexcel Pharma Technologies Ltd. Improved release of statins in the intestine
US9289418B2 (en) 2013-03-15 2016-03-22 Cedars-Sinai Medical Center Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
AU2014239164B2 (en) 2013-03-15 2018-12-06 Cedars-Sinai Medical Center Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
RU2697851C2 (en) 2014-08-13 2019-08-21 Седарс-Синаи Медикал Сентер Antimetanogenic compositions and use thereof
EP3277274B1 (en) 2015-04-01 2024-06-12 Cedars-Sinai Medical Center Anti-methanogenic lovastatin analogs or derivatives and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366738A (en) * 1982-07-29 1994-11-22 Merck & Co., Inc. Controlled release drug dispersion delivery device
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
US5244916A (en) * 1992-01-31 1993-09-14 The Scripps Research Institute Inhibition of respiratory burst using posttranslational modification inhibitors
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
IN176897B (en) * 1993-10-29 1996-09-28 Cadila Lab Ltd
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device

Also Published As

Publication number Publication date
GB2371748A (en) 2002-08-07
GB2371748B (en) 2004-12-01
NZ518770A (en) 2004-02-27
AU768950B2 (en) 2004-01-08
WO2001034123A1 (en) 2001-05-17
GB0210619D0 (en) 2002-06-19
HK1050134A1 (en) 2003-06-13
CA2390301A1 (en) 2001-05-17
IL149524A0 (en) 2002-11-10
AU1360701A (en) 2001-06-06

Similar Documents

Publication Publication Date Title
DK1223918T3 (en) Pharmaceutical compositions comprising an HMG-CoA reductase inhibitor
ATE253576T1 (en) 8-QUINOLINXANTHINE AND 8-ISOCHINOLINXANTHINE DERIVATIVES AS PDE 5 INHIBITORS
PL359820A1 (en) Hmg-coa reductase inhibitors and method
ATE318603T1 (en) PYRROLOTRIAZINE KINASE INHIBITORS
HUP0104258A3 (en) Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor
AU2001240542A1 (en) Heterocyclic compounds and their use as parp inhibitors
IL183920A0 (en) A COMBINATION FORMULATION OF A 3-HYDROXY-3 - METHYL GLUTARYL CoA REDUCTASE INHIBITOR AND AN ANTIHYPERTENSIVE AGENT AND PROCESSES FOR THE PREPARATION THEREOF
IL159588A0 (en) Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor
DE50013473D1 (en) Pyrrole derivatives as phosphodiesterase VII inhibitor
AU2001275870A1 (en) Methods and kits for the detection of arginine compounds
AU2002211618A1 (en) Light sensitive compounds for instant determination of organ function
AU3368400A (en) Aerosol compositions of hmg-coa reductase inhibitors for inhibiting inflammationassociated with pulmonary disease
PT1171440E (en) 3-CYAN- ¬ 1,7 |, | 1,5 |, E ¬ 1,8 | -TREOSINE KINASE INHIBITOR INHIBITORS
AU2003250172A1 (en) Compositions comprising hmg-coa reductase inhibitor
DE10085183T1 (en) Preparation of an HMG-COA reductase inhibitor with prolonged release
AU2001296864A1 (en) Detection of varicella-zoster virus
AU4543699A (en) Multibinding inhibitors of hmg-coa reductase
AU5680900A (en) Combination of mtp inhibitors and hmg-coa reductase inhibitors and the use thereof in medicaments
AU2001270908A1 (en) Methods for detection of human papillomavirus mrna
AU2001280461A1 (en) Substituted pyrrole compounds and their use as spla2 inhibitors
DE50212235D1 (en) MAGNETJOCH OF ELECTROMAGNETIC RELEASE
AU2001251004A1 (en) Detection of viable agents
EP1404313A4 (en) METHYL ANALOGS OF SIMVASTATIN AS NOVEL HMG-CoA REDUCTASE INHIBITORS
AU4988100A (en) Use of hmgcoa reductase inhibitors in the prevention of diseases whose pathogenesis is dependent on neovascularization
HUP0201597A2 (en) Antilipemic combunations comprising hmg-coa reductase inhibitors and carnitines

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8125 Change of the main classification

Ipc: A61K 31/235

8127 New person/name/address of the applicant

Owner name: ANDRX LABS LLC,, DAVIE, FLA., US

8131 Rejection